课题基金 / 基金详情

Mechanisms and Models of Testis Specific Serine Kinase 6 (TSSK6)

Mechanisms and Models of Testis Specific Serine Kinase 6 (TSSK6)
睾丸特异性丝氨酸激酶 6 (TSSK6) 的机制和模型
批准号:
9811702
负责人:
Angelique Wright Whitehurst
金额:
$16.3万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-04 至 2021-08-31

项目摘要

项目成果

Angelique Wright Whitehurst的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 睾丸特异性丝氨酸激酶家族(TSSK)的成员对精子成熟和 生育能力。然而,TSSK信号级联仍然定义不清。在这个家庭中,只有TSSK6是 被归类为癌症-睾丸基因(CT-基因),因为其表达在广泛的范围内异常激活 癌症类型。我们发现TSSK6可以促进肿瘤前细胞的致癌行为。在……里面 在这个提议中,我们将描绘癌症中依赖TSSK6的信号通路,并确定如何 这一途径支持致瘤表型。此外,我们将开发细胞系、抗体和 为进一步研究这一特性不佳的激酶提供额外的试剂。这项工作将建立 TSSK6在肿瘤中异常表达和存在时发挥作用的分子机制 为未来的研究提供更多的实验工具。
英文摘要
Abstract Members of the Testis Specific Serine Kinases family (TSSK) are essential for sperm maturation and fertility. However, the TSSK signaling cascades remain poorly defined. Of this family, only TSSK6 is classified as a cancer-testis gene (CT-gene) as its expression is anomalously activated in a wide range of cancer types. We have found that TSSK6 can promote oncogenic behavior in pre-neoplastic cells. In this proposal, we will delineate the TSSK6-dependent signaling pathway in cancer and determine how this pathway supports tumorigenic phenotypes. In addition, we will develop cell lines, antibodies and additional reagents for further study of this poorly characterized kinase. This work will establish the molecular mechanism by which TSSK6 functions when anomalously expressed in tumors and present additional experimental tools for future investigations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The sperm specific protein, COX6B2, promotes metabolic reprogramming in lung adenocarcinoma
  • 批准号:
    10297376
  • 项目类别:
  • 资助金额:
    $37.52万
  • 财政年份:
    2021
  • 负责人:
    Angelique Wright Whitehurst
  • 依托单位:
The sperm specific protein, COX6B2, promotes metabolic reprogramming in lung adenocarcinoma
  • 批准号:
    10490396
  • 项目类别:
  • 资助金额:
    $36.76万
  • 财政年份:
    2021
  • 负责人:
    Angelique Wright Whitehurst
  • 依托单位:
The sperm specific protein, COX6B2, promotes metabolic reprogramming in lung adenocarcinoma
  • 批准号:
    10683739
  • 项目类别:
  • 资助金额:
    $36.76万
  • 财政年份:
    2021
  • 负责人:
    Angelique Wright Whitehurst
  • 依托单位:
Framing Therapeutic Opportunities in Tumor-Activated Gametogenic Programs
  • 批准号:
    9257334
  • 项目类别:
  • 资助金额:
    $37.06万
  • 财政年份:
    2016
  • 负责人:
    Angelique Wright Whitehurst
  • 依托单位:
海外基金